COMPANY
Primetime Life Sciences, LLC
Timeline
- Grant Government grant — SBIR: $1M (annual award, as published), announced Jun 25, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Funding
- Government grant — SBIR: $1M (annual award, as published), announced Jun 25, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
NIH awards 7
- NIH award 5R44AI165220-03 FY2024: $915,901 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of PTLS-209 for treatme source ↗
- NIH award 4R44AI165220-02 FY2023: $633,977 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of PTLS-209 for treatme source ↗
- NIH award 1R44AI165220-01A1 FY2022: $300,000 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of PTLS-209 for treat source ↗
- NIH award 5R44MH116741-04 FY2021: $935,028 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of an adenosine A1 rece source ↗
- NIH award 5R44MH116741-03 FY2020: $840,580 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of an adenosine A1 rece source ↗
- NIH award 4R44MH116741-02 FY2019: $807,479 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of an adenosine A1 rece source ↗
- NIH award 1R44MH116741-01A1 FY2018: $350,042 awarded for that fiscal year; activity R44 (SBIR); PI PADIA, JANAK K; recipient as written: PRIMETIME LIFE SCIENCES, LLC, GERMANTOWN, MD. Development of an adenosine A1 re source ↗